Bioethics Biotechnology FDA Health Law Policy Human Subjects Research Pharmaceuticals Public Health Sravya Chary Vaccines
coronavirus pandemic
-
-
Authorize Emergency Vaccines for COVID-19, but Do It Well
Read more: Authorize Emergency Vaccines for COVID-19, but Do It Well -
The Problem with Individual-Level Interventions to Curb the COVID-19 Pandemic
Read more: The Problem with Individual-Level Interventions to Curb the COVID-19 Pandemic -
Bioethics FDA Featured Health Law Policy Nicolas Terry Public Health Race Resource Allocation Social Determinants of Health VaccinesAdvance Health Equity by Getting Vaccine Distribution Right
Read more: Advance Health Equity by Getting Vaccine Distribution Right -
Amending the Public Health Service Act to Encourage CDC Action to Stop COVID-19
Read more: Amending the Public Health Service Act to Encourage CDC Action to Stop COVID-19 -
Why the Government Shouldn’t Pay People to Get Vaccinated Against COVID-19
Read more: Why the Government Shouldn’t Pay People to Get Vaccinated Against COVID-19 -
Under an EUA, Can Businesses Require Employees and Customers to Get Vaccinated?
Read more: Under an EUA, Can Businesses Require Employees and Customers to Get Vaccinated? -
What Does the Good News on the Vaccine Front Mean?
Read more: What Does the Good News on the Vaccine Front Mean? -
Health Care Finance Health Law Policy Insurance Patient Care Pharmaceuticals Public Health Reimbursement Sravya CharyCuts to 340B Drug Reimbursement May be Harmful During COVID-19
Read more: Cuts to 340B Drug Reimbursement May be Harmful During COVID-19 -
Biotechnology FDA Featured Health Law Policy Human Subjects Research Influenza Pharmaceuticals Public Health Sravya CharyExperts Question FDA Approval of Remdesivir for COVID-19
Read more: Experts Question FDA Approval of Remdesivir for COVID-19